Targeting the Mitochondria-Proteostasis Axis to Delay Aging

Area of Science:

• Gerontology and cellular biology
• Molecular mechanisms of aging

Background:

• Increasing human life expectancy correlates with a rise in age-related chronic diseases, imposing significant societal burdens.
• Current treatments often address single comorbidities, lacking holistic approaches for multifaceted age-related dysfunctions.
• There is a critical need for novel therapies targeting the fundamental processes of aging itself.

Purpose of the Study:

• To summarize current anti-aging strategies focused on mitochondria and protein homeostasis.
• To highlight the role of autophagy in mitochondrial quality control and its link to aging.
• To explore the therapeutic potential of targeting the mitochondria-proteostasis axis.

Main Methods:

• Review of genetic and pharmacological interventions affecting aging.
• Focus on molecular targets within mitochondria and pathways promoting autophagy.
• Analysis of the interplay between mitochondria and protein homeostasis (autophagy).

Main Results:

• Specific interventions targeting mitochondria and pro-autophagic pathways demonstrate efficacy in extending healthspan and lifespan.
• Autophagy plays a crucial role in maintaining mitochondrial quality control.
• The crosstalk between mitochondria and autophagy, termed the mitochondria-proteostasis axis, is a key target.

Conclusions:

• Targeting mitochondria and protein homeostasis, especially autophagy, represents a viable strategy for combating age-related diseases.
• Interventions modulating the mitochondria-proteostasis axis hold significant promise for developing effective anti-aging therapies.
• Further research into this axis could unlock maximal therapeutic potential for extending human healthspan.